Businesses that manufacture, import, distribute, or otherwise handle products regulated by the Philippine Food and Drug Administration (FDA) may need more than ordinary business registration before they can legally operate. Depending on the activity and product category, an FDA License to Operate (LTO) is required before an establishment can conduct covered activities involving regulated health products.
The license to operate in the Philippines is particularly important for businesses involved in cosmetics, food, drugs, medical devices, and other products under FDA regulation. It is an establishment-level authorization, meaning it concerns the business conducting the regulated activity rather than serving as approval for every individual product.
The regulatory framework changed significantly when the FDA issued Administrative Order No. 2024-0015, which repealed Administrative Order No. 2020-0017. The newer rules revised LTO requirements, application procedures, validity periods, and the FDA’s approach to licensing.
For entrepreneurs planning to establish an FDA-regulated business in the Philippines, understanding the difference between ordinary business registration, an FDA LTO, and product authorization is essential.
What Is a License to Operate in the Philippines?
The LTO is an FDA authorization that allows a covered establishment to conduct activities involving products under the agency’s regulatory jurisdiction. The specific type of LTO depends on the establishment’s activities and the health products it handles.
Under the FDA’s licensing framework, establishments involved in regulated activities must secure the appropriate authorization before undertaking activities covered by FDA regulations. The FDA has also emphasized that an establishment may need both an LTO and a separate product authorization, such as a Certificate of Product Notification (CPN) for cosmetics, depending on the product involved.
This distinction is important because obtaining an LTO does not automatically mean that every product a company sells is authorized.
For example, a cosmetics business may have to address two separate regulatory requirements:
- An LTO for the establishment conducting the regulated activity
- A Cosmetic Product Notification for each applicable cosmetic product
The FDA has specifically warned that cosmetic products should not be distributed without the appropriate establishment authorization and product notification.
Which Businesses May Need an FDA LTO?
The requirement depends on the nature of the business and the products involved. FDA regulation covers several major health product categories, including cosmetics, food, drugs, medical devices, and household or urban hazardous substances.
Businesses that may fall within FDA licensing requirements include establishments that:
- Manufacture regulated health products
- Import regulated products
- Export regulated products
- Distribute regulated products
- Wholesale regulated products
- Trade certain regulated products
- Conduct other FDA-regulated activities covered by the applicable rules
The exact licensing category matters because the documentary, technical, and operational requirements can differ depending on whether the establishment is a manufacturer, trader, distributor, importer, exporter, or another covered establishment. Administrative Order No. 2024-0015 provides the current framework for licensing covered health product establishments.
Businesses should therefore determine the appropriate FDA classification before preparing an application. Registering a company with the Securities and Exchange Commission (SEC) or registering a sole proprietorship with the Department of Trade and Industry (DTI) does not by itself satisfy FDA licensing requirements.
Why Cosmetics Businesses Need to Pay Particular Attention
Cosmetics businesses are one of the areas where the distinction between company registration and FDA authorization is especially important.
A company may be properly incorporated or have a registered business name, but that does not automatically authorize it to manufacture, import, distribute, or place cosmetic products on the Philippine market.
The FDA’s Center for Cosmetics and Household/Urban Hazardous Substances Regulation and Research regulates cosmetic establishments and cosmetic products. Under the Philippine framework implementing the ASEAN Cosmetic Directive, businesses responsible for placing cosmetic products on the Philippine market must comply with the applicable notification and regulatory requirements.
The FDA has also continued updating the Philippine implementation of the ASEAN Cosmetic Directive. In 2025, the agency disseminated consolidated amendments concerning cosmetic ingredients and restrictions and reminded stakeholders that cosmetic products placed or already in the Philippine market must comply with the applicable ACD standards, subject to Philippine-specific grace periods where provided.
For a cosmetics company, regulatory compliance therefore needs to cover both the establishment and its products.
Business Registration Should Come Before the FDA Application
Before applying for an FDA LTO, the business needs to establish its legal identity and operating information.
The FDA’s LTO requirements have historically required proof of business registration. For example, FDA licensing requirements recognize DTI registration for a single proprietorship and SEC registration for corporations, partnerships, and other juridical entities.
This creates an important sequence for entrepreneurs:
- Determine the appropriate business structure.
- Register the business with the appropriate government agency.
- Establish the business address and relevant operating arrangements.
- Complete applicable local and tax registrations.
- Determine the FDA-regulated activity.
- Apply for the appropriate FDA LTO.
- Complete applicable product notification or registration requirements.
The exact sequence can vary depending on the business model, but entrepreneurs should not treat FDA licensing as a substitute for ordinary business registration.
Determine the Correct FDA LTO Category
Correct classification is one of the most important parts of the application because the FDA does not issue one generic license covering every possible health product activity.
The business should first determine what it actually does with the regulated product.
For example, the regulatory requirements can differ between a company that:
- Manufactures cosmetics locally
- Imports finished cosmetics
- Distributes cosmetics
- Trades products manufactured by another company
- Operates as a wholesaler
- Performs manufacturing-related activities such as packing or repacking where covered
The FDA’s previous licensing framework expressly distinguished manufacturers, traders, and distributors, and the newer AO 2024-0015 continues the activity-based approach while updating the licensing rules.
A company should therefore avoid selecting a license category simply because it appears closest to its business name. The declared activity should correspond to the actual operations of the establishment.
Prepare the Documents Required for the LTO
Once the correct category has been identified, the next step is to prepare the application documents.
Administrative Order No. 2024-0015 revised the requirements for initial, renewal, and variation applications. The specific documents depend on the establishment and activity, but applicants should expect the FDA application to require information concerning the business, its regulated activity, and its compliance arrangements.
For an initial application, the requirements can include:
- Accomplished FDA electronic application
- Declaration and Undertaking
- Proof of business name registration
- Proof of the FDA-regulated activity
- Financial information where required
- Risk Management Plan
- Site Master File for covered manufacturers
- List of sources, authorized suppliers, or clients where applicable
- Applicable technical documents
- Payment of the prescribed fees
The precise requirements should always be checked against the current FDA rules for the particular establishment category.
For manufacturers, the documentation can be more extensive because the FDA needs information about the facility, manufacturing processes, quality systems, and risk controls.
Understand the Role of the Qualified Person
Businesses applying for an FDA LTO should also pay close attention to the Qualified Person (QP).
The QP is not simply an employee listed on the application. The role is connected to the establishment’s technical and regulatory responsibilities. Under the FDA framework, the QP is expected to have appropriate technical competence and to support the establishment’s compliance with applicable regulatory requirements.
For cosmetics establishments, the requirements can depend on whether the establishment is a manufacturer, trader, or distributor. Earlier FDA guidance identified appropriate allied-health qualifications and, for manufacturers, certain registered professionals such as chemists, chemical engineers, or pharmacists, together with relevant training.
Businesses should therefore confirm the current qualification requirements applicable to their particular LTO category rather than assuming that any employee can be designated as the QP.
This is particularly important for manufacturers because the technical responsibilities associated with production and product quality are greater than those of a company that simply distributes finished products.
Submit the Application Through the FDA’s Electronic System
The FDA has progressively moved its licensing processes toward electronic systems.
Older guidance referenced the FDA e-Portal, while the agency has been developing and implementing the FDA eServices Portal System to streamline licensing and regulatory transactions. The FDA has stated that its eServices system is intended to support electronic LTO applications and other regulatory transactions.
Applicants should therefore use the current FDA platform and instructions applicable to their establishment rather than relying on older articles that describe account-creation procedures or submission methods from previous systems.
The electronic application requires the business to provide accurate information about the establishment. Inconsistencies between the application and supporting documents can create problems during evaluation.
Important information can include:
- Registered business name
- Establishment address
- Office and warehouse locations
- Contact information
- Nature of regulated activity
- Qualified Person information
- Supporting business documents
- Technical and compliance documents
Businesses should review the application carefully before submission because incorrect information can lead to delays, requests for clarification, or regulatory action.
Prepare the Facility for FDA Compliance
For businesses operating physical facilities, obtaining an LTO is not simply an online paperwork exercise.
Depending on the establishment and application, FDA regulatory processes may involve inspection and evaluation of the facility against applicable standards. The updated licensing framework under AO 2024-0015 places greater emphasis on the licensing and inspection process, including pre-licensing inspections for covered applications.
A manufacturer should therefore prepare its facility before applying rather than waiting until an inspection is scheduled.
Areas that may need attention include:
- Facility layout
- Storage conditions
- Manufacturing areas
- Sanitation and hygiene controls
- Equipment
- Documentation systems
- Quality procedures
- Product handling
- Traceability
- Risk management
- Personnel responsibilities
The precise technical standards depend on the regulated product and activity.
A business that applies before its facility and documentation are ready may create unnecessary delays in the licensing process.
Know the Difference Between LTO and Product Authorization
One of the most common regulatory misunderstandings is treating the establishment license as product approval.
The two are separate.
An LTO authorizes the establishment to conduct the covered regulated activity. Product authorization addresses the individual product and can take different forms depending on the product category.
For cosmetics, the relevant product authorization is generally the Certificate of Product Notification (CPN) rather than a general Certificate of Product Registration. The FDA’s cosmetic notification materials explain that cosmetic products must be notified in each ASEAN country where they are marketed.
The FDA also explains that acceptance of a cosmetic notification does not mean the authority has guaranteed that the product complies with every regulatory requirement. Responsibility remains with the company placing the product on the market.
This means a compliant cosmetics business must consider both:
Establishment compliance: Is the company properly licensed for its FDA-regulated activity?
Product compliance: Are the individual cosmetic products properly notified and compliant with applicable requirements?
Both areas should be addressed before commercial distribution.
Understand the New LTO Validity Periods
One of the significant changes introduced by AO 2024-0015 concerns the validity of an FDA LTO.
Under the current framework, the validity period is based on enterprise classification. The initial LTO is valid for:
- Three years for micro and small enterprises
- Six years for medium and large enterprises
For renewals, the validity is:
- Six years for micro and small enterprises
- Twelve years for medium and large enterprises
These periods are established under AO 2024-0015.
This is different from older guidance that described shorter LTO validity periods. Businesses should therefore be cautious when relying on older online articles about FDA licensing.
The longer validity periods do not mean that the company can ignore compliance after receiving the license. The FDA retains regulatory authority over licensed establishments, and businesses remain responsible for complying with applicable requirements throughout the validity period.
Plan for LTO Renewal in Advance
A long validity period can make compliance management easier, but it can also cause businesses to lose track of renewal dates.
The FDA temporarily extended the renewal filing window to 180 days before expiration in February 2025 while addressing the implementation issues with AO 2024-0015. That interim measure was later lifted. Effective June 30, 2025, the FDA restored the prescribed 90-calendar-day renewal period before LTO expiration.
Businesses should therefore maintain a regulatory calendar showing:
- LTO issue date
- LTO expiration date
- Earliest renewal filing date
- Responsible compliance personnel
- Required renewal documents
- Applicable fees
- Any outstanding FDA variations or regulatory matters
Waiting until the license is close to expiration can create operational risk, particularly if additional documentation or regulatory review is required.
Keep the FDA Information Updated
An FDA LTO is not a permanent authorization to operate under any circumstances.
Changes to the establishment can create the need for a variation application or other regulatory action.
Potential changes may include:
- Business address
- Warehouse location
- Regulated activities
- Ownership or business information
- Qualified Person
- Sources or suppliers
- Clients
- Facility arrangements
- Other information covered by the FDA variation rules
The appropriate action depends on the nature of the change. Businesses should not assume that an existing LTO automatically covers a substantially different activity or location.
Maintaining accurate FDA records is particularly important for companies that expand their operations after receiving their initial license.
Pay Attention to Cosmetic Product Compliance
For businesses entering the cosmetics sector, obtaining the LTO is only one part of regulatory preparation.
Cosmetic products must comply with the ASEAN Cosmetic Directive and applicable Philippine FDA requirements. This includes restrictions and requirements concerning cosmetic ingredients, product information, labeling, and notification.
The Philippine FDA continues to issue updates concerning amendments to the ACD. In its 2025 announcement, the FDA specifically reminded stakeholders that cosmetic products placed on or already in the Philippine market must comply with the applicable ACD standards, subject to applicable Philippine grace periods.
Businesses should therefore review formulations and regulatory documents before launching a product rather than treating product notification as a simple administrative filing.
For imported cosmetics, businesses should also establish who is responsible for placing the product on the Philippine market and ensure that the local regulatory documentation is consistent with the actual business arrangement.
Understand the Cost of FDA Licensing
FDA licensing costs depend on the establishment type, activity, application, and applicable fee schedule.
The FDA issued Administrative Order No. 2024-0016 to establish a new schedule of fees and charges. The FDA subsequently issued guidance concerning implementation of the new fee schedule and related application charges.
For cosmetics, the FDA fee schedule provides separate fee categories for manufacturers and distributor/trader establishments, as well as separate fees for cosmetic product notification. The applicable fee should be confirmed through the current FDA payment and application system before filing.
Businesses should budget for more than the government filing fee itself. Depending on the business, additional costs may involve:
- Regulatory consulting
- Qualified technical personnel
- Facility preparation
- Product testing
- Quality documentation
- Compliance systems
- Product notification
- Local permits
- Import-related requirements
A realistic regulatory budget should therefore be prepared before the business launches.
Why FDA Compliance Should Be Planned With Business Registration
For entrepreneurs, FDA licensing should be considered part of the overall business setup rather than an issue to address after commercial operations begin.
The business structure, registered activities, premises, personnel, product sourcing arrangements, and regulatory responsibilities should be considered together.
For example, a company planning to import and distribute cosmetics may need to coordinate:
- Corporate or business registration
- Local business permits
- Tax registration
- FDA LTO
- Cosmetic product notification
- Import and customs requirements
- Product labeling and compliance
- Ongoing FDA obligations
Addressing these requirements separately without considering how they interact can lead to inconsistent business information and unnecessary delays.
A business registration plan that identifies regulatory requirements at the beginning can make the launch process more organized and reduce the risk of beginning sales before the required authorizations are in place.
Final Insights
Obtaining a license to operate in the Philippines is an important regulatory step for businesses conducting activities involving FDA-regulated health products. It is separate from DTI or SEC business registration and should also be distinguished from product-level authorization.
For cosmetics businesses, the distinction is especially important. The establishment may require an FDA LTO, while individual cosmetic products may also need the appropriate notification and must comply with the ASEAN Cosmetic Directive and the Philippine FDA requirements.
The current LTO framework is governed principally by Administrative Order No. 2024-0015, which replaced AO 2020-0017 and introduced revised licensing requirements and longer validity periods. The FDA framework now provides initial validity of three years for micro and small enterprises and six years for medium and large enterprises, while renewal validity can extend to six and twelve years, respectively.
Businesses should focus on getting the establishment classification, business documents, qualified personnel, technical requirements, facility, and product compliance requirements correct before beginning regulated commercial activities.
Get Expert Assistance
Applying for a license to operate in the Philippines can involve several regulatory requirements, particularly when the business is entering the cosmetics, food, medical device, pharmaceutical, or other regulated sectors. Business owners also need to coordinate FDA licensing with their general business registration, local permits, tax registration, and product-specific requirements.
BusinessRegistrationPhilippines.com can assist entrepreneurs and foreign investors in understanding the Philippine business registration process and coordinating the requirements involved in establishing a compliant business:
- Contact Us Here
- Fill Out the Form Below
- Call us at +63 (02) 8540-9623